Fortrea (FTRE) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $22.75, +6.58% vs the prior close of $21.34.
- Volume 2.91M shares, 2.0x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
FTRE jumps 6.6% to $22.75, a 52-week high on 2.0x normal volume. Closed at $22.75, +6.58% vs the prior close of $21.34. Day range $21.63–$23.07, opened at $21.93.
FTRE daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — FTRE jumps 6.6% to $22.75, a 52-week high on 2.0x normal volume
- Closed at $22.75, +6.58% vs the prior close of $21.34. Day range $21.63–$23.07, opened at $21.93.
- Volume was 2.91M shares, 2.0x its 50-day average of 1.43M — unusually heavy trading.
- Price is +18.9% vs its 50-day average ($19.12) and +48.1% vs its 200-day average ($15.36).
- 52-week range $8.55–$23.51; today's close sits at 95% of that range, 3.3% below the 52-week high.
Oct 14, 2026 — FTRE rises 2.0% to $21.34, a 52-week high on 2.1x normal volume
- Closed at $21.34, +2.01% vs the prior close of $20.92. Day range $20.25–$22.15, opened at $20.45.
- Volume was 2.94M shares, 2.1x its 50-day average of 1.42M — unusually heavy trading.
- Price is +12.0% vs its 50-day average ($19.05) and +39.2% vs its 200-day average ($15.33).
- 52-week range $8.55–$23.51; today's close sits at 85% of that range, 9.2% below the 52-week high.
Oct 13, 2026 — FTRE dips 0.4% to $20.92
- Closed at $20.92, -0.38% vs the prior close of $21.00. Day range $20.60–$21.22, opened at $21.11.
- Volume was 764.30K shares, 0.5x its 50-day average of 1.47M — lighter than usual.
- Price is +10.2% vs its 50-day average ($18.98) and +36.6% vs its 200-day average ($15.31).
- 52-week range $8.55–$23.51; today's close sits at 83% of that range, 11.0% below the 52-week high.
Oct 12, 2026 — FTRE rises 0.8% to $21.00
- Closed at $21.00, +0.77% vs the prior close of $20.84. Day range $20.67–$21.31, opened at $20.84.
- Volume was 1.24M shares, 0.8x its 50-day average of 1.48M.
- Price is +10.9% vs its 50-day average ($18.94) and +37.3% vs its 200-day average ($15.30).
- 52-week range $8.55–$23.51; today's close sits at 83% of that range, 10.7% below the 52-week high.
Oct 9, 2026 — FTRE rises 2.3% to $20.84
- Closed at $20.84, +2.31% vs the prior close of $20.37. Day range $20.16–$21.00, opened at $20.37.
- Volume was 931.30K shares, 0.6x its 50-day average of 1.50M.
- Price is +10.2% vs its 50-day average ($18.91) and +36.4% vs its 200-day average ($15.28).
- 52-week range $8.55–$23.51; today's close sits at 82% of that range, 11.4% below the 52-week high.
Oct 8, 2026 — FTRE dips 0.9% to $20.37, 3 down days in a row
- Closed at $20.37, -0.92% vs the prior close of $20.56. Day range $19.78–$20.45, opened at $20.14.
- Volume was 1.96M shares, 1.3x its 50-day average of 1.53M.
- Price is +7.9% vs its 50-day average ($18.87) and +33.4% vs its 200-day average ($15.26).
- 52-week range $8.55–$23.51; today's close sits at 79% of that range, 13.4% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — FTRE dips 1.1% to $20.56
- Closed at $20.56, -1.06% vs the prior close of $20.78. Day range $20.24–$21.11, opened at $20.38.
- Volume was 2.25M shares, 1.5x its 50-day average of 1.55M.
- Price is +8.9% vs its 50-day average ($18.87) and +34.8% vs its 200-day average ($15.25).
- 52-week range $8.55–$23.51; today's close sits at 80% of that range, 12.5% below the 52-week high.
Oct 6, 2026 — FTRE dips 1.6% to $20.78
- Closed at $20.78, -1.56% vs the prior close of $21.11. Day range $20.73–$23.51, opened at $21.99.
- Volume was 2.65M shares, 1.7x its 50-day average of 1.52M.
- Price is +10.1% vs its 50-day average ($18.88) and +36.4% vs its 200-day average ($15.23).
- 52-week range $8.55–$23.51; today's close sits at 82% of that range, 11.6% below the 52-week high.
Oct 5, 2026 — FTRE jumps 5.6% to $21.11, a 52-week high
- Closed at $21.11, +5.55% vs the prior close of $20.00. Day range $19.85–$21.20, opened at $20.00.
- Volume was 2.27M shares, 1.5x its 50-day average of 1.50M.
- Price is +12.0% vs its 50-day average ($18.84) and +38.8% vs its 200-day average ($15.21).
- 52-week range $8.55–$21.39; today's close sits at 98% of that range, 1.3% below the 52-week high.
Oct 2, 2026 — FTRE jumps 3.1% to $20.00
- Closed at $20.00, +3.09% vs the prior close of $19.40. Day range $19.09–$20.05, opened at $19.58.
- Volume was 1.19M shares, 0.8x its 50-day average of 1.51M.
- Price is +6.3% vs its 50-day average ($18.81) and +31.7% vs its 200-day average ($15.18).
- 52-week range $8.55–$21.39; today's close sits at 89% of that range, 6.5% below the 52-week high.
FTRE latest news & SEC filings
Every SEC filing by or about FTRE in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 30, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 14, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 11, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 10, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Russell Carrie Elizabeth sold 246 shares at $16.85 (≈$4.15K) on Sep 9, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 10, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Morais Mark A. sold 3,149 shares at $16.85 (≈$53.06K) on Sep 9, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 10, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 10, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 9, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Jul 29, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $678.20M (prior year $710.30M) (-4.5% vs Jun 30, 2025)
- Net income: -$13.20M (prior year -$374.90M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.14 (prior year -$4.14) (loss narrowed vs Jun 30, 2025)
Jul 29, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 14, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jun 26, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade FTRE
- Last results release: Jul 29, 2026 (8-K Item 2.02). Previous ones: May 5, 2026, Feb 26, 2026, Nov 5, 2025. Based on that rhythm, the next report is likely around Oct 28, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.12% (largest 6.6%).
- Liquidity: about 1.70M shares (≈$38.64M) trade per day on average.
- 52-week position: $22.75 vs a range of $8.55–$23.51 (95% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 24 sales; latest: Carrie Elizabeth Russell sold 246 shares on Sep 9, 2026.
- Latest filings: 8-K Sep 30, 2026; 8-K Sep 10, 2026; 10-Q Jul 29, 2026.
- Share count: 95.10M shares outstanding (Jul 27, 2026), +4.7% vs a year earlier.
- Listing: Nasdaq · industry: Services-Medical Laboratories.
FTRE market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 21.93 | 23.07 | 21.63 | 22.75 | 2.91M |
| Oct 14, 2026 | 20.45 | 22.15 | 20.25 | 21.34 | 2.94M |
| Oct 13, 2026 | 21.11 | 21.22 | 20.60 | 20.92 | 764.30K |
| Oct 12, 2026 | 20.84 | 21.31 | 20.67 | 21.00 | 1.24M |
| Oct 9, 2026 | 20.37 | 21.00 | 20.16 | 20.84 | 931.30K |
| Oct 8, 2026 | 20.14 | 20.45 | 19.78 | 20.37 | 1.96M |
| Oct 7, 2026 | 20.38 | 21.11 | 20.24 | 20.56 | 2.25M |
| Oct 6, 2026 | 21.99 | 23.51 | 20.73 | 20.78 | 2.65M |
| Oct 5, 2026 | 20.00 | 21.20 | 19.85 | 21.11 | 2.27M |
| Oct 2, 2026 | 19.58 | 20.05 | 19.09 | 20.00 | 1.19M |
| Oct 1, 2026 | 19.88 | 19.96 | 19.05 | 19.40 | 1.94M |
| Sep 30, 2026 | 19.41 | 20.02 | 19.39 | 19.95 | 1.48M |
| Sep 29, 2026 | 19.89 | 20.39 | 19.42 | 19.74 | 1.17M |
| Sep 28, 2026 | 19.54 | 20.97 | 19.35 | 20.06 | 1.62M |
| Sep 25, 2026 | 19.90 | 20.28 | 19.35 | 19.89 | 708.90K |
| Sep 24, 2026 | 19.40 | 20.49 | 19.25 | 20.02 | 1.23M |
| Sep 23, 2026 | 20.25 | 20.71 | 19.50 | 19.52 | 1.07M |
| Sep 22, 2026 | 20.13 | 20.58 | 20.13 | 20.43 | 1.51M |
| Sep 21, 2026 | 20.29 | 20.44 | 19.67 | 20.02 | 1.05M |
| Sep 18, 2026 | 20.10 | 20.22 | 19.28 | 19.93 | 3.11M |
About Fortrea
Fortrea (FTRE) is listed on the Nasdaq and classified by the SEC under “Services-Medical Laboratories”. Its business address is in DURHAM, NC. Fiscal year ends December 31. SEC CIK 1965040.
FTRE board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Peter M Neupert | Director | Jun 12, 2026 |
| Edward A Pesicka | Director | Jun 12, 2026 |
| Amrit Ray | Director | Jun 12, 2026 |
| Erin L Russell | Director | Jun 12, 2026 |
| Machelle Sanders | Director | Aug 5, 2026 |
| William J Sharbaugh | Director | Jun 12, 2026 |
| David Ross Smith | Interim CFO | Aug 5, 2026 |
| Anshul Thakral | Chief Executive Officer | Aug 7, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jason Fredrick Knoblauch | Chief Financial Officer | Sep 14, 2026 |
| Jill G. Mcconnell | Chief Financial Officer | Jun 3, 2026 |
| Mark A. Morais | Chief Operating Officer | Sep 10, 2026 |
| Robert Parks | Chief Accounting Officer | May 20, 2026 |
| Carrie Elizabeth Russell | Interim CAO | Sep 10, 2026 |
| David Ross Smith | Interim CFO | Aug 5, 2026 |
| Anshul Thakral | Chief Executive Officer | Aug 7, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 9, 2026 | Carrie Elizabeth Russell | Sale | 246 | $16.85 |
| Sep 9, 2026 | Mark A. Morais | Sale | 3,149 | $16.85 |
| Aug 19, 2026 | Mark A. Morais | Sale | 4,892 | $18.19 |
| Aug 6, 2026 | Anshul Thakral | Sale | 55,882 | $18.17 |
| Aug 6, 2026 | Anshul Thakral | Sale | 55,975 | $18.06 |
| Aug 5, 2026 | Anshul Thakral | Sale | 49,452 | $19.03 |
| Aug 5, 2026 | Anshul Thakral | Sale | 50,417 | $19.28 |
| Aug 3, 2026 | Machelle Sanders | Sale | 9,700 | $18.01 |
| Jun 10, 2026 | Mark A. Morais | Sale | 4,674 | $16.82 |
| Jun 2, 2026 | Jill G. Mcconnell | Sale | 4,866 | $15.49 |
| Jun 2, 2026 | Mark A. Morais | Sale | 4,866 | $15.49 |
| May 18, 2026 | Robert Parks | Sale | 2,000 | $13.44 |
| Mar 16, 2026 | Jill G. Mcconnell | Sale | 1,804 | $9.22 |
| Mar 16, 2026 | Mark A. Morais | Sale | 1,804 | $9.22 |
| Mar 10, 2026 | Robert Parks | Sale | 963 | $8.93 |
FTRE financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $2.72B | $-986.20M | -10.81 | $113.50M |
| Dec 31, 2024 | $2.70B | $-328.50M | -3.67 | $262.80M |
| Dec 31, 2023 | $2.84B | $-25.20M | -0.29 | $168.40M |
| Dec 31, 2022 | $2.84B | $186.20M | 2.09 | $82.70M |
| Dec 31, 2021 | $3.06B | $98.00M | 1.10 | $169.80M |
Latest balance sheet: total assets $2.71B, total liabilities $2.19B, cash $168.60M (as of Jun 30, 2026).
FTRE earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 29, 2026 | 8-K Item 2.02 (results) | $20.40 |
| May 5, 2026 | 8-K Item 2.02 (results) | $14.53 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $10.80 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $11.95 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $6.58 |
| May 12, 2025 | 8-K Item 2.02 (results) | $5.19 |
| Mar 3, 2025 | 8-K Item 2.02 (results) | $10.38 |
| Nov 8, 2024 | 8-K Item 2.02 (results) | $23.50 |
| Aug 12, 2024 | 8-K Item 2.02 (results) | — |
| May 13, 2024 | 8-K Item 2.02 (results) | — |
| Mar 11, 2024 | 8-K Item 2.02 (results) | — |
| Jan 8, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Medical Laboratories
Natera (NTRA)Quest Diagnostics (DGX)Guardant Health (GH)Labcorp (LH)Celcuity (CELC)Caris Life Sciences (CAI)Grail (GRAL)CareDx (CDNA)Veracyte (VCYT)BillionToOne (BLLN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on FTRE
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.